how does the body make glp 1 Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review The GLP-1 journey: from discovery

And I would expect in the future in a post shortage world, this also continues to exist for patients as an access point

Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years

Ozempic: The clinical trials Both Mounjaro and Ozempic/Wegovy have been extensively studied in clinical trials for both safety and effectiveness, including in the long term

The theoretical synergy of this stack in a research context lies in the convergence of these pathways